No connection

Search Results

MYSE

BEARISH
$1.47 Live
Myseum, Inc. · NASDAQ
$1.31 52W Range $3.65

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 15, 2026
Market cap
$6.36M
P/E
N/A
ROE
-96.9%
Profit margin
N/A
Debt/Equity
0.04
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
Myseum, Inc. exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. The company's operational efficiency is catastrophic, evidenced by an operating margin of -998,192.40% and a Price/Sales ratio of 11,557.75, which suggests negligible revenue relative to its market valuation. While the balance sheet shows low debt and high short-term liquidity, these are overshadowed by a -96.90% ROE and a consistent multi-year price collapse. The lack of analyst coverage and a 0/100 technical trend further reinforce a high-risk, bearish outlook.

Key Strengths

Low Debt/Equity ratio (0.04)
Strong Current Ratio (4.29) indicating short-term liquidity
Strong Quick Ratio (4.03)
Price is trading close to Book Value (P/B 1.03)
Minimal long-term debt burden

Key Risks

Extreme operational inefficiency with catastrophic operating margins
Negligible revenue generation relative to market cap (P/S > 11,000)
Negative Return on Equity (-96.90%) and Return on Assets (-54.60%)
Declining quarterly revenue growth (-33.70%)
Severe long-term price erosion (-95.7% over 5 years)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
8
Weak
Value
5
Future
10
Past
5
Health
20
Dividend
0
AI Verdict
Distressed / High Risk
Key drivers: Piotroski F-Score of 1/9, Absurd Price/Sales ratio, Negative growth and profitability, Bearish technical trend
Confidence
90%
Value
5/100

Graham Number is unavailable; valuation is disconnected from revenue.

Positives
  • P/B ratio near 1.0
Watchpoints
  • P/S ratio of 11,557.75 is non-functional
  • No P/E or PEG available due to lack of earnings
Future
10/100

Growth metrics are negative and deteriorating.

Positives
No standout positives identified.
Watchpoints
  • Q/Q Revenue growth is -33.70%
  • No evidence of a path to profitability
Past
5/100

Historical performance shows a near-total loss of shareholder value.

Positives
No standout positives identified.
Watchpoints
  • 5-year price change of -95.7%
  • Consistent downward trend across all timeframes
Health
20/100

Liquidity is the only positive, but operational health is failing.

Positives
  • Low Debt/Equity
  • High Current Ratio
Watchpoints
  • Piotroski F-Score 1/9
  • Severe negative ROE/ROA
Dividend
0/100

Company is not in a position to return capital.

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.47

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MYSE and closest competitors.

Updated 2026-04-14
MYS
Myseum, Inc.
Primary
5Y
-95.7%
3Y
-70.9%
1Y
-39.3%
6M
-52.4%
1M
-12.0%
1W
-3.3%
AGP
Axe Compute Inc.
Peer
5Y
-99.6%
3Y
-98.0%
1Y
-88.1%
6M
-86.3%
1M
-24.4%
1W
+6.6%
ORK
Orangekloud Technology Inc.
Peer
5Y
-95.5%
3Y
-95.5%
1Y
-58.5%
6M
-45.5%
1M
-1.0%
1W
+3.0%
DAI
CID HoldCo, Inc.
Peer
5Y
-99.5%
3Y
-99.5%
1Y
-99.5%
6M
-93.2%
1M
-19.3%
1W
+14.1%
CYC
Cycurion, Inc.
Peer
5Y
-98.7%
3Y
-98.7%
1Y
-90.2%
6M
-83.7%
1M
-21.3%
1W
+27.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
1.03
P/S Ratio
11557.8
EV/Revenue
5172.36
EV/EBITDA
-0.52
Market Cap
$6.36M

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin -998192.0%
Gross Margin N/A
ROE -96.9%
ROA -54.6%

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth -33.7%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.04
Low debt
Current Ratio
4.29
Strong
Quick Ratio
4.03
Excellent
Cash/Share
$0.86

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
-1124950.8%
Op. Margin
-1872431.1%
Net Margin
2105365.6%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.18x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
101%

Technology Sector Comparison

Comparing MYSE against 383 companies in the Technology sector (32 bullish, 137 neutral, 214 bearish)
Return on Equity (ROE)
-96.9%
This Stock
vs
-35.13%
Sector Avg
+175.8% (Excellent)
Debt to Equity
0.04
This Stock
vs
0.67
Sector Avg
-94.7% (Less Debt)
Current Ratio
4.29
This Stock
vs
3.83
Sector Avg
+12.1% (Better)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning MYSE from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile